Omega Healthcare Investors (OHI) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
5 Feb, 2026Company profile and strategy
Listed since 1992, with $11.4B in real estate investments and $17.9B enterprise value as of September 2025.
Operates 1,024 properties across the US, UK, and Jersey, with 93,159 beds and 88 operators.
Maintains investment grade credit (BBB-) and a 6.3% dividend yield.
Management team averages over 20 years of industry experience.
Focuses on long-term shareholder value through accretive investments, financial strength, and solid dividend growth.
Investment thesis and portfolio strengths
Diversified portfolio with long leases, quality operators, and consistent high-yield growth.
Triple-net leases and prudent rent escalators provide stable earnings and tenant durability.
Conservative balance sheet, significant liquidity, and proven capital market access.
Positioned to benefit from demographic tailwinds and limited new supply.
Trades at 13.4x AFFO with 6.5% annualized AFFO growth since 2004.
Skilled nursing facilities (SNFs) market dynamics
SNFs are the primary discharge destination for Medicare patients, offering the lowest cost for post-acute 24-hour care.
Primarily funded through Medicare and Medicaid, with average occupancy at 82.6%.
Regulatory restrictions limit new supply, with 86% of states having moratoriums or CON restrictions.
SNFs deliver the highest investment yields among healthcare real estate assets, averaging 9.4% over five years.
Latest events from Omega Healthcare Investors
- Strong 2025 results and 2026 outlook driven by higher earnings, investments, and portfolio strength.OHI
Q4 20255 Feb 2026 - Q2 net income and FFO rose, AFFO guidance increased, but operator and regulatory risks remain.OHI
Q2 20242 Feb 2026 - Q3 FAD and net income rose, AFFO guidance raised, but operator and regulatory risks persist.OHI
Q3 202417 Jan 2026 - Q4 delivered strong growth, decade-low leverage, and a robust 2025 outlook with U.K. investments.OHI
Q4 20248 Jan 2026 - Q1 2025 net income and AFFO rose sharply, driving higher guidance and robust investments.OHI
Q1 202525 Dec 2025 - Board recommends FOR all proposals, citing strong performance and enhanced ESG focus.OHI
Proxy Filing1 Dec 2025 - Board recommends voting for all proposals, citing strong performance and governance.OHI
Proxy Filing1 Dec 2025 - Shareholders will vote on more authorized shares, auditor ratification, and allow brokers discretionary voting.OHI
Proxy Filing1 Dec 2025 - Q3 2025 delivered higher earnings, raised guidance, and strong investment-driven growth.OHI
Q3 20251 Nov 2025